SEC Form D private-offering filing

Goldenrod Therapeutics, Inc.

Name: Goldenrod Therapeutics, Inc. - new SEC Form D private-offering filing, Houston, TX
Published: 2026-06-03

A new SEC Form D private-offering notice from Houston, TX, a $6,510,000 filer-stated offering target in Biotech. The source filing is one click away.

Goldenrod Therapeutics, Inc. site↗ Verified via SEC Form D

Develops next generation PDE4 inhibitor drugs for neurological conditions including Friedreich's ataxia and substance use disorders

Filed 2026-06-03Filed to raise $6,510,000First money in 2026-05-26Raised so far $3,245,355HQ (as filed) Houston, TXSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified goldenrodtx.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.